IDEVvsSBIO
iShares Core MSCI International Developed Markets ETF against ALPS Medical Breakthroughs ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | SBIO | |
|---|---|---|
| Expense ratio | 0.040% | 0.50% |
| Assets | $32.2B | $114M |
| Net flow, 1 month | +$892M | — |
| Net flow, 1 year | +$7.3B | — |
| Return, YTD | +8.6% | +9.6% |
| Return, 1 year | +10.9% | +43.9% |
| Avg daily volume | 1.9M | 41K |
| Holdings | 2281 | 95 |
| Listed | Mar 21, 2017 | Dec 30, 2014 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS